Search Results for: dana-farber boston children's AND research
Targeted small-molecule agent shows early promise against a dangerous infant leukemia
Leukemias involving reshuffling or rearrangement of the mixed lineage leukemia (MLL) gene, known as MLL-rearranged or MLL-r leukemias, account for …Read More
A potential Diamond-Blackfan anemia treatment swims into view
Zebrafish, besides being popular in aquariums, make good stand-ins for studying human diseases. They share about 70 percent of their …Read More
A big step toward curbing graft-vs.-host disease after bone marrow transplant
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use. …Read More
Unlocking a treatment for diffuse intrinsic pontine glioma
Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive and one of the most difficult-to-treat childhood tumors. It’s the second most …Read More
Teen author dedicates a children’s book to her twin brother with Shwachman-Diamond syndrome
Sophia Namazy, 14, has a hero: it’s her twin brother Max, who has Shwachman-Diamond syndrome. This is a rare and …Read More
Most parents of children with advanced cancer don’t recognize their low chance of cure
End-of-life care for children with advanced cancer is often very intensive, and can cause much suffering. When parents recognize that …Read More
Following clinical trial, boy with Fanconi anemia transfusion free
Seven-year-old Ervis of Chicago, Illinois, is a model student with a positive attitude and a megawatt smile. His mom Ofelia …Read More
Meet BORIS: A new culprit in drug-resistant cancer?
Like a Russian bot corrupting U.S. elections, or a new prime minister wreaking havoc in the U.K., a protein named …Read More
A series of coincidences unite two people to fight childhood cancer
When Lauren Wolinski accepted a job as a summer intern in the oncology unit at Boston Children’s Hospital, she could …Read More
In high-risk neuroblastoma, two stem cell transplants may be better than one
Since the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of care for high-risk …Read More